Preparation of hierarchical mesoporous CaCO3 by a facile binary solvent approach as anticancer drug carrier for etoposide

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-11

  Peng, Haibao ^a   Li, Kun ^a   Wang, Ting ^a   Wang, Jin ^a   Wang, Jiao ^a   Zhu, Rongrong ^a   Sun, Dongmei ^a   Wang, Shilong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITE; CALCIUM CARBONATE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; DRUG PRODUCTS; EFFICIENCY; NANOSPHERES; TARGETED DRUG DELIVERY;

DRUG DELIVERY SYSTEM; DRUG-LOADING EFFICIENCY; FORMATION PROCESS; HIERARCHICAL STRUCTURES; INHIBITION EFFECT; INTRACELLULAR DELIVERY; NORMAL TEMPERATURE AND PRESSURES; PHYSICAL ABSORPTION;

CONTROLLED DRUG DELIVERY;

EID: 84881250683     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-321     Document Type: Article

References (54)

1. Bisht S, Maitra A: Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wires Nanomed Nanobi 2009, 1:415-425.
2. Li RH, Hehlman R, Sachs R, Duesberg P: Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells. Cancer Genet Cytogen 2005, 163:44-56.
3. Chilkoti A, Dreher MR, Meyer DE, Raucher D: Targeted drug delivery by thermally responsive polymers. Adv Drug Deliver Rev 2002, 54:613-630.
4. Duesberg P, Li RH, Sachs R, Fabarius A, Upender MB, Hehlmann R: Cancer drug resistance: the central role of the karyotype. Drug Resist Update 2007, 10:51-58.
5. Luo GF, Xu XD, Zhang J, Yang J, Gong YH, Lei Q, Jia HZ, Li C, Zhuo RX, Zhang XZ: Encapsulation of an adamantane-doxorubicin prodrug in pHresponsive polysaccharide capsules for controlled release. Acs Appl Mater Inter 2012, 4:5317-5324.
6. Shah JC, Chen JR, Chow D: Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res 1989, 6:408-412.
7. Shi JJ, Votruba AR, Farokhzad OC, Langer R: Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010, 10:3223-3230.
8. Wang J, Chen JS, Zong JY, Zhao D, Li F, Zhuo RX, Cheng SX: Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery. J Phys Chem C 2010, 114:18940-18945.
9. Ferrari M: Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
10. Jones D: Cancer nanotechnology: small, but heading for the big time. Nat Rev Drug Discov 2007, 6:174-175.
11. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
12. Chawla JS, Amiji MM: Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002, 249:127-138.
13. Feng XL, Lv FT, Liu LB, Tang HW, Xing CF, Yang QO, Wang S: Conjugated polymer nanoparticles for drug delivery and imaging. Acs Appl Mater Inter 2010, 2:2429-2435.
14. Zhao Y, Lin LN, Lu Y, Chen SF, Dong L, Yu SH: Templating synthesis of preloaded doxorubicin in hollow mesoporous silica nanospheres for biomedical applications. Adv Mater 2010, 22:5255-5259.
15. Hou ZQ, Zhan CM, Jiang QW, Hu Q, Li L, Chang D, Yang XR, Wang YX, Li Y, Ye SF, Xie L, Yi Y, Zhang Q: Both FA-and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution. Nanoscale Res Lett 2011, 6(1):563.
16. Li XR, Yang ZL, Yang KW, Zhou YX, Chen XW, Zhang YH, Wang F, Liu Y, Ren LJ: Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen. Nanoscale Res Lett 2009, 4:1502-1511.
17. Li XR, Zhang YH, Fan YT, Zhou YX, Wang XN, Fan C, Liu Y, Zhang Q: Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett 2011, 6(1):275.
18. Marquez F, Herrera GM, Campo T, Cotto M, Duconge J, Sanz JM, Elizalde E, Perales O, Morant C: Preparation of hollow magnetite microspheres and their applications as drugs carriers. Nanoscale Res Lett 2012, 7(1):210.
19. Wei W, Ma GH, Hu G, Yu D, Mcleish T, Su ZG, Shen ZY: Preparation of hierarchical hollow CaCO3 particles and the application as anticancer drug carrier. J Am Chem Soc 2008, 130:15808-15810.
20. Helmlinger G, Yuan F, Dellian M, Jain RK: Interstitial pH and pO(2) gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997, 3:177-182.
21. He XW, Liu T, Chen YX, Cheng DJ, Li XR, Xiao Y, Feng YL: Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. Cancer Gene Ther 2008, 15:193-202.
22. Ueno Y, Futagawa H, Takagi Y, Ueno A, Mizushima Y: Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release 2005, 103:93-98.
23. Zhao D, Liu CJ, Zhuo RX, Cheng SX: Alginate/CaCO3 hybrid nanoparticles for efficient codelivery of antitumor gene and drug. Mol Pharmaceut 2012, 9:2887-2893.
24. Thomas JA, Seton L, Davey RJ, DeWolf CE: Using a liquid emulsion membrane system for the encapsulation of organic and inorganic substrates within inorganic microcapsules. Chem Commun 2002, 10:1072-1073.
25. Walsh D, Lebeau B, Mann S: Morphosynthesis of calcium carbonate (vaterite) microsponges. Adv Mater 1999, 11:324-328.
26. Arnold AM: Podophyllotoxin derivative VP 16-213. Cancer Chemother Pharmacol 1979, 3:71-80.
27. Greenspan EM, Leiter J, Shear MJ: Effect of alpha-peltatin, beta-peltatin, podophyllotoxin on lymphomas and other transplanted tumors. J Natl Cancer Inst 1950, 10:1295-1333.
28. Gordaliza M, Castro MA, del Corral JM, Feliciano AS: Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 2000, 6:1811-1839.
29. Park S, Lim JH, Chung SW, Mirkin CA: Self-assembly of mesoscopic metalpolymer amphiphiles. Science 2004, 303:348-351.
30. Zhang YJ, Yao Q, Zhang Y, Cui TY, Li D, Liu W, Lawrence W, Zhang ZD: Solvothermal synthesis of magnetic chains self-assembled by flowerlike cobalt submicrospheres. Cryst Growth Des 2008, 8:3206-3212.
31. Zhang ZP, Gao DM, Zhao H, Xie CG, Guan GJ, Wang DP, Yu SH: Biomimetic assembly of polypeptide-stabilized CaCO3 nanoparticles. J Phys Chem B 2006, 110:8613-8618.
32. Caruso F: Hollow capsule processing through colloidal templating and self-assembly. Chem-Eur J 2000, 6:413-419.
33. Caruso F: Nanoengineering of particle surfaces. Adv Mater 2001, 13:11-+.
34. Caruso F, Caruso RA, Mohwald H: Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating. Science 1998, 282:1111-1114.
35. Jiang P, Bertone JF, Colvin VL: A lost-wax approach to monodisperse colloids and their crystals. Science 2001, 291:453-457.
36. Li YS, Shi JL, Hua ZL, Chen HR, Ruan ML, Yan DS: Hollow spheres of mesoporous aluminosilicate with a three-dimensional pore network and extraordinarily high hydrothermal stability. Nano Lett 2003, 3:609-612.
37. Sun YG, Mayers B, Xia YN: Metal nanostructures with hollow interiors. Adv Mater 2003, 15:641-646.
38. Ma XM, Li LP, Yang L, Su CY, Guo YM, Jiang K: Preparation of highly ordered hierarchical CaCO3 hemisphere and the application as pH value-sensitive anticancer drug carrier. Mater Lett 2011, 65:3176-3179.
39. Du JM, Liu ZM, Li ZH, Han BX, Huang Y, Zhang JL: Synthesis of mesoporous SrCO3 spheres and hollow CaCO3 spheres in roomtemperature ionic liquid. Micropor Mesopor Mat 2005, 83:145-149.
40. Sun DM, Wu QS, Ding YP: A novel method for crystal control: synthesis and design of strontium carbonate with different morphologies by supported liquid membrane. J Appl Crystallogr 2006, 39:544-549.
41. Qian WY, Sun DM, Zhu RR, Du XL, Liu H, Wang SL: pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release. Int J Nanomed 2012, 7:5781-5792.
42. Hou YW, Kong AG, Zhao XH, Zhu HY, Shan YK: Synthesis of high surface area mesoporous carbonates in novel ionic liquid. Mater Lett 2009, 63:1061-1064.
43. Wang LC, Chen XG, Liu CS, Li PW, Zhou PM: Dissociation behaviors of carboxyl and amine groups on carboxymethyl-chitosan in aqueous system. J Polym Sci Pol Phys 2008, 46:1419-1429.
44. Bailly C: Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy. Chem Rev 2012, 112:3611-3640.
45. Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL: The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 2002, 277:16547-16552.
46. Ariga K, Lvov YM, Kawakami K, Ji QM, Hill JP: Layer-by-layer self-assembled shells for drug delivery. Adv Drug Deliver Rev 2011, 63:762-771.
47. Iyer AK, Khaled G, Fang J, Maeda H: Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006, 11:812-818.
48. Maeda H: The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001, 41:189-207.
49. Barreto JA, O'Malley W, Kubeil M, Graham B, Stephan H, Spiccia L: Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011, 23:H18-H40.
50. Norman RS, Stone JW, Gole A, Murphy CJ, Sabo-Attwood TL: Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett 2008, 8:302-306.
51. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M: Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008, 3:151-157.
52. Zhao Y, Lu Y, Hu Y, Li JP, Dong L, Lin LN, Yu SH: Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy. Small 2010, 6:2436-2442.
53. Firth JA: Endothelial barriers: from hypothetical pores to membrane proteins. J Anat 2002, 200:541-548.
54. Rejman J, Oberle V, Zuhorn IS, Hoekstra D: Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 2004, 377:159-169.